Skip to main content

Oyler John's Form 4 filing

BeOne Medicines Ltd. (ONC) · filed Jul 14, 2026

Accession no.
0001042047-26-000013
Filed
Jul 14, 2026, 9:26 PM ET
Trade date
Jul 14, 2026
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $44.6M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Oyler JohnCIK 0001042047Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 14, 2026American Depositary SharesSSaleDisposed−4,139$303.07F8−$1,254,401.358,122Direct
Jul 14, 2026American Depositary SharesSSaleDisposed−8,122$303.93F9−$2,468,490.220Direct
Jul 14, 2026American Depositary SharesMOption exerciseAcquired+97,282$36.90+$3,589,705.897,282Direct
Jul 14, 2026American Depositary SharesMOption exerciseAcquired+36,318$100.04+$3,633,252.72133,600Direct
Jul 14, 2026American Depositary SharesSSaleDisposed−39,090$305.02F10−$11,923,259.1694,510Direct
Jul 14, 2026American Depositary SharesSSaleDisposed−45,895$306.21F11−$14,053,627.2848,615Direct
Jul 14, 2026American Depositary SharesSSaleDisposed−40,781$306.93F12−$12,517,112.167,834Direct
Jul 14, 2026American Depositary SharesSSaleDisposed−7,834$307.57F13−$2,409,533.930Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 14, 2026Ordinary SharesMOption exerciseDisposed−1,264,666$0.00$00Direct
Jul 14, 2026Ordinary SharesMOption exerciseDisposed−472,134$0.00$0462,866Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.48 to $303.46, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.54 to $304.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.45 to $305.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.455 to $306.45, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F12

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.455 to $307.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F13

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.46 to $307.87, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)